Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus

Posted 2025-04-08, Nasdaq Globe Newswire Headlines

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus ...... read full story

Ask about this article

Answer for your question of the article will be displayed here ...